secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK:        0001314052
Form:       8-K
Filed at:   2021-09-13T23:59:59+00:00
Accession:  0001731122-21-001498
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anavex presents at H.C. Wainwright conference; no material new information filed
--------------------------------------------------------------------------------

- Presented corporate deck at H.C. Wainwright 23rd Annual Global Investment Conference on Sep 13, 2021.
- CEO Christopher Missling delivered the presentation via webcast.
- No financial results, pipeline updates, or guidance disclosed in the 8-K filing.
- Exhibit 99.1 investor presentation is furnished but not filed with the SEC.
- Filing is a Regulation FD disclosure without substantive operational details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314052/000173112221001498/0001731122-21-001498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314052/000173112221001498/e3088_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-21-001498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer